The Community Guide

- gsearch

Search Results

Narrow Results:

2024 2
2023 1
2022 1
2021 2
2019 1
2018 1
2016 1
2015 1
2008 1

Botswana 1

Journal Article 11

1 - 11 of 11 Results

Refine Results

Refine Results:

Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitabine as Pre-exposure Prophylaxis (PreP) Clinical Trial, Botswana, 2007-2010

CITE Title : Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitabine as Pre-exposure Prophylaxis (PreP) Clinical Trial, Botswana, 2007-2010 Personal Author(s) : Kebaabetswe, Poloko M.;Stirratt, Michael J.;McLellan-Lemal, Eleanor;Henderson, Faith L.;Gray, Simone C.;Rose, Charles E.;Williams, Tiffany;Paxton, Lynn A.; Published Date : May 2015 Source : AIDS Behav. 19(5):758-769. URL : https://stacks.cdc.gov/view/cdc/34535 Kebaabetswe, Poloko M. et al. (2015). Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitabine as Pre-exposure Prophylaxis (PreP) Clinical Trial, Botswana, 2007-2010. 19(5). Kebaabetswe, Poloko M. et al. "Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitabine as Pre-exposure Prophylaxis (PreP) Clinical Trial, Botswana, 2007-2010" 19, no. 5 (2015) Kebaabetswe, Poloko M. et al. "Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitabine as Pre-exposure Prophylaxis (PreP) Clinical Trial, Botswana, 2007-2010" vol. 19, no. 5, 2015 Export RIS Citation Information.

:

Kebaabetswe, Poloko M. ;

Stirratt, Michael J.

May 2015 | AIDS Behav. 19(5):758-769.

:

This study examined study product adherence and its determinants in the Botswana oral pre-exposure prophylaxis efficacy trial. Among the 1,219 partici...
Antiretroviral drug exposure in urethral and glans surface sampling of the penis

CITE Title : Antiretroviral drug exposure in urethral and glans surface sampling of the penis Personal Author(s) : Haaland, Richard E.;Fountain, Jeffrey;Dinh, Chuong;Lupo, L. Davis;Martin, Amy;Conway-Washington, Christopher;Hall, LaShonda;Kelley, Colleen F.;Garcia-Lerma, J. Gerardo;Heneine, Walid; Published Date : 8 12 2021;8-12-; Source : J Antimicrob Chemother. 76(9):2368-2374 URL : https://stacks.cdc.gov/view/cdc/127691 Haaland, Richard E. et al. (2021). Antiretroviral drug exposure in urethral and glans surface sampling of the penis. 76(9). Haaland, Richard E. et al. "Antiretroviral drug exposure in urethral and glans surface sampling of the penis" 76, no. 9 (2021) Haaland, Richard E. et al. "Antiretroviral drug exposure in urethral and glans surface sampling of the penis" vol. 76, no. 9, 2021 Export RIS Citation Information.

:

Haaland, Richard E.

;

Fountain, Jeffrey

8 12 2021 | J Antimicrob Chemother. 76(9):2368-2374

:

Background:HIV exposure to penile tissues provides a risk of acquisition among men, yet studies evaluating penile antiretroviral (ARV) drug distributi...
Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays

CITE Title : Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays Personal Author(s) : Haaland, Richard E.;Martin, Amy;Mengesha, Melkam;Dinh, Chuong;Fountain, Jeffrey;Lupo, L. Davis;Hall, LaShonda;Conway-Washington, Christopher;Kelley, Colleen F.; Published Date : 10 2021;10-2021; Source : AIDS Res Hum Retroviruses. 37(10):744-747 URL : https://stacks.cdc.gov/view/cdc/127690 Haaland, Richard E. et al. (2021). Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays. 37(10). Haaland, Richard E. et al. "Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays" 37, no. 10 (2021) Haaland, Richard E. et al. "Short Communication: Evaluation of Antiretroviral Drug Concentrations in Minimally Invasive Specimens for Potential Development of Point-of-Care Drug Assays" vol. 37, no. 10, 2021 Export RIS Citation Information.

:

Haaland, Richard E. ;

Martin, Amy

10 2021 | AIDS Res Hum Retroviruses. 37(10):744-747

:

Point-of-care (POC) tests for antiretroviral drugs (ARVs) could help improve individual adherence. This study sought to define the utility of urine, b...
Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures

CITE Title : Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures Personal Author(s) : Srinivasan, Priya;Moss, John A.;Gunawardana, Manjula;Churchman, Scott A.;Yang, Flora;Dinh, Chuong T.;Mitchell, James M.;Zhang, Jining;Fanter, Rob;Miller, Christine S.;Butkyavichene, Irina;McNicholl, Janet M.;Smith, Thomas J.;Baum, Marc M.;Smith, James M.; Published Date : Jun 08 2016 Source : PLoS One. 11(6). URL : https://stacks.cdc.gov/view/cdc/40117 Srinivasan, Priya et al. (2016). Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures. 11(6). Srinivasan, Priya et al. "Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures" 11, no. 6 (2016) Srinivasan, Priya et al. "Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures" vol. 11, no. 6, 2016 Export RIS Citation Information.

:

Srinivasan, Priya ;

Moss, John A.

Jun 08 2016 | PLoS One. 11(6).

:

Topical preexposure prophylaxis (PrEP) against HIV has been marginally successful in recent clinical trials with low adherence rates being a primary f...
Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men

CITE Title : Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men Personal Author(s) : Haaland, Richard E.;Martin, Amy;Livermont, Tamee;Fountain, Jeffrey;Dinh, Chuong;Holder, Angela;Lupo, Lindsey D.;Hall, LaShonda;Conway-Washington, Christopher;Kelley, Colleen F.; Published Date : November 01 2019 Source : J Acquir Immune Defic Syndr. 82(3):252-256 URL : https://stacks.cdc.gov/view/cdc/95046 Haaland, Richard E. et al. (2019). Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men. 82(3). Haaland, Richard E. et al. "Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men" 82, no. 3 (2019) Haaland, Richard E. et al. "Urine Emtricitabine and Tenofovir Concentrations Provide Markers of Recent Antiretroviral Drug Exposure Among HIV-Negative Men Who Have Sex With Men" vol. 82, no. 3, 2019 Export RIS Citation Information.

:

Haaland, Richard E. ;

Martin, Amy

November 01 2019 | J Acquir Immune Defic Syndr. 82(3):252-256

:

Background:Urine provides a minimally invasive specimen that may allow for development of rapid tests to detect antiretroviral drugs and provide oppor...
Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir

CITE Title : Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir Personal Author(s) : García-Lerma, J. Gerardo;Otten, Ron A;Qari, Shoukat H;Jackson, Eddie;Cong, Mian-er;Masciotra, Silvina;Luo, Wei;Kim, Caryn;Adams, Debra R;Monsour, Michael;Lipscomb, Jonathan;Johnson, Jeffrey A;Delinsky, David;Schinazi, Raymond F;Janssen, Robert;Folks, Thomas M;Heneine, Walid; Published Date : Feb 2008 Source : PLoS Med. 2008; 5(2). URL : https://stacks.cdc.gov/view/cdc/4212 García-Lerma, J. Gerardo et al. (2008). Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir. 5(2). García-Lerma, J. Gerardo et al. "Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir" 5, no. 2 (2008) García-Lerma, J. Gerardo et al. "Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir" vol. 5, no. 2, 2008 Export RIS Citation Information.

:

García-Lerma, J. Gerardo ;

Otten, Ron A

Feb 2008 | PLoS Med. 2008; 5(2).

:

BackgroundIn the absence of an effective vaccine, HIV continues to spread globally, emphasizing the need for novel strategies to limit its transmissio...
Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study

CITE Title : Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study Personal Author(s) : Sawry, Shobna;Ayalew, Kassahun;Maimela, Gloria;Briggs-Hagen, Melissa;van Wyk-Heath, Marelize;Mthethwa, Simangele;Shai, Sannie;Mngomezulu, Nkululeko N.;Tlhowe, Lawrence;Achere-Darko, Josephine;Bedford, Jason;Martin, Catherine E.;Fairlie, Lee;Imrie, John; Published Date : 7 2024;7-2024; Source : HIV Med. 25(7):826-839 URL : https://stacks.cdc.gov/view/cdc/159349 Sawry, Shobna et al. (2024). Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study. 25(7). Sawry, Shobna et al. "Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study" 25, no. 7 (2024) Sawry, Shobna et al. "Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study" vol. 25, no. 7, 2024 Export RIS Citation Information.

:

Sawry, Shobna

;

Ayalew, Kassahun

7 2024 | HIV Med. 25(7):826-839

:

Introduction:Although dolutegravir (DTG) is deemed stable, safe, cost-effective, and clinically beneficial, it also carries the risk of side effects, ...
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants

CITE Title : Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants Personal Author(s) : Jacobson, Denise L.;Crider, Krista S.;DeMarrais, Patricia;Brummel, Sean;Zhang, Mindy;Pfeiffer, Christine M.;Moore, Cynthia A.;McCarthy, Katie;Johnston, Benjamin;Mohammed, Terence;Vhembo, Tichaona;Kabugho, Enid;Muzorah, Gerald Agaba;Cassim, Haseena;Fairlie, Lee;Machado, Elizabeth S.;Ngocho, James S.;Shapiro, Roger L.;Serghides, Lena;Chakhtoura, Nahida;Chinula, Lameck;Lockman, Shahin; Published Date : 6 15 2024;11-15-; Source : J Infect Dis. 230(5):1224-1234 URL : https://stacks.cdc.gov/view/cdc/170000 Jacobson, Denise L. et al. (2024). Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants. 230(5). Jacobson, Denise L. et al. "Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants" 230, no. 5 (2024) Jacobson, Denise L. et al. "Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants" vol. 230, no. 5, 2024 Export RIS Citation Information.

:

Jacobson, Denise L.

;

Crider, Krista S.

6 15 2024 | J Infect Dis. 230(5):1224-1234

:

Background.In the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) 2010/VESTED study, pregnant women were randomized to init...
Impact of the Early COVID-19 Pandemic on the Number of HIV Pre-Exposure Prophylaxis (PrEP) Uses and the Proportion of PrEP users receiving STI Testing Services

CITE Title : Impact of the Early COVID-19 Pandemic on the Number of HIV Pre-Exposure Prophylaxis (PrEP) Uses and the Proportion of PrEP users receiving STI Testing Services Personal Author(s) : Schmidt, Mark A.;Salas, Suzanne B.;Donald, Judy L.;Gift, Thomas L.;Tao, Guoyu; Published Date : 5 2023;5-01-; Source : Sex Transm Dis. 50(5):304-309 URL : https://stacks.cdc.gov/view/cdc/127175 Schmidt, Mark A. et al. (2023). Impact of the Early COVID-19 Pandemic on the Number of HIV Pre-Exposure Prophylaxis (PrEP) Uses and the Proportion of PrEP users receiving STI Testing Services. 50(5). Schmidt, Mark A. et al. "Impact of the Early COVID-19 Pandemic on the Number of HIV Pre-Exposure Prophylaxis (PrEP) Uses and the Proportion of PrEP users receiving STI Testing Services" 50, no. 5 (2023) Schmidt, Mark A. et al. "Impact of the Early COVID-19 Pandemic on the Number of HIV Pre-Exposure Prophylaxis (PrEP) Uses and the Proportion of PrEP users receiving STI Testing Services" vol. 50, no. 5, 2023 Export RIS Citation Information.

:

Schmidt, Mark A. ;

Salas, Suzanne B.

5 2023 | Sex Transm Dis. 50(5):304-309

:

Background:With potential impact of the COVID-19 pandemic on HIV PrEP care management, we assessed the number of PrEP users and STI-testing-eligible P...
The predictive value of macaque models of preexposure prophylaxis for HIV prevention

CITE Title : The predictive value of macaque models of preexposure prophylaxis for HIV prevention Personal Author(s) : García-Lerma, J. Gerardo;McNicholl, Janet M.;Heneine, Walid; Published Date : 7 01 2022;7-01-; Source : Curr Opin HIV AIDS. 17(4):179-185 URL : https://stacks.cdc.gov/view/cdc/153575 García-Lerma, J. Gerardo et al. (2022). The predictive value of macaque models of preexposure prophylaxis for HIV prevention. 17(4). García-Lerma, J. Gerardo and McNicholl, Janet M. and Heneine, Walid "The predictive value of macaque models of preexposure prophylaxis for HIV prevention" 17, no. 4 (2022) García-Lerma, J. Gerardo et al. "The predictive value of macaque models of preexposure prophylaxis for HIV prevention" vol. 17, no. 4, 2022 Export RIS Citation Information.

:

García-Lerma, J. Gerardo ;

McNicholl, Janet M.

7 01 2022 | Curr Opin HIV AIDS. 17(4):179-185

:

Purpose of reviewWe review macaque models for preexposure prophylaxis (PrEP) for HIV prevention and highlight their role in advancing currently approv...
Getting PrEP to the people: opportunities, challenges, and emerging models of PrEP implementation

CITE Title : Getting PrEP to the people: opportunities, challenges, and emerging models of PrEP implementation Personal Author(s) : Sullivan, Patrick S;Siegler, Aaron J; Published Date : 11 2018;11-2018; Source : Sex Health. 15(6):522-527 URL : https://stacks.cdc.gov/view/cdc/164649 Sullivan, Patrick S and Siegler, Aaron J (2018). Getting PrEP to the people: opportunities, challenges, and emerging models of PrEP implementation. 15(6). Sullivan, Patrick S and Siegler, Aaron J "Getting PrEP to the people: opportunities, challenges, and emerging models of PrEP implementation" 15, no. 6 (2018) Sullivan, Patrick S and Siegler, Aaron J "Getting PrEP to the people: opportunities, challenges, and emerging models of PrEP implementation" vol. 15, no. 6, 2018 Export RIS Citation Information.

:

Sullivan, Patrick S ;

Siegler, Aaron J

11 2018 | Sex Health. 15(6):522-527

:

Background/Purpose:Pre-exposure prophylaxis with TDF/FTC is now accepted as an efficacious approach to preventing HIV acquisition among people at high...